Skip to content
Exploring New Possibilities in Vitiligo Therapy episode artwork

Apr 19, 2022 10 min

Exploring New Possibilities in Vitiligo Therapy

from HCPLive Podcasts Hosted by HCPLive.com

An estimated 2 million patients in the United States have vitiligo, which is a dermatologic condition defined by depigmentation of the skin. Though there is currently no cure, recent medical advancements have helped patients and providers alike gain a broader perspective on the skin condition. Likewise, prominent cultural figures with vitiligo have also contributed addressing the stigma surrounding the disease. Despite this, vitiligo is still considered by many to be solely a cosmetic condition, though it is very much a medical condition as well. Sarah Asch, MD, FAAP, FAAD, Society of Pediatric Dermatology , Teledermatology Committee Chair, spoke of how the public perception of vitiligo has evolved in recent years, as well as how vitiligo affects adults and pediatric patients differently and the myriad of promising new therapies that are currently being explored.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Exploring New Possibilities in Vitiligo Therapy

0:00 10:59

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of HCPLive Podcasts?

This episode is 10 minutes long.

When was this HCPLive Podcasts episode published?

This episode was published on April 19, 2022.

Can I download this HCPLive Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.